These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6942193)

  • 1. Reaction of immune complexes with Hodgkin's disease tissue cultures.
    Long JC; Dvorak AM; Quay SC; Stamatos C
    J Natl Cancer Inst; 1981 Jul; 67(1):3. PubMed ID: 6942193
    [No Abstract]   [Full Text] [Related]  

  • 2. [Circulating immune complexes in the serum in Hodgkin's disease].
    Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
    Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes as markers of Hodgkin's disease activity].
    Urbaniak-Kujda D
    Pol Tyg Lek; 1996 May; 51(19-22):303-4. PubMed ID: 9289719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI; Bostick-Bruton F
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating immune complexes in the serum of patients with Hodgkin's disease].
    Berényi E; Kávai M; Pálkövi E; Szegedi G
    Orv Hetil; 1979 Jan; 120(2):79-82. PubMed ID: 760038
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin disease--pathogenesis and therapy].
    Wolf J; Diehl V
    Ther Umsch; 1996 Feb; 53(2):140-6. PubMed ID: 8629264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 expression in Hodgkin's disease.
    O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS
    Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.
    Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.
    von Wasielewski R; Wilkens L; Nolte M; Werner M; Georgii A
    Mod Pathol; 1996 Mar; 9(3):334-8. PubMed ID: 8685237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor correlation between clonal immunoglobulin gene rearrangement and immunoglobulin gene transcription in Hodgkin's disease.
    Yatabe Y; Oka K; Asai J; Mori N
    Am J Pathol; 1996 Oct; 149(4):1351-61. PubMed ID: 8863682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reactions in classical Hodgkin's lymphoma.
    Poppema S; Potters M; Emmens R; Visser L; van den Berg A
    Semin Hematol; 1999 Jul; 36(3):253-9. PubMed ID: 10462325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity reaction in Hodgkin's disease].
    FABIANI F
    Prog Med (Napoli); 1957 Jan; 13(2):57-61. PubMed ID: 13420207
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune neutropenia in Hodgkin's disease.
    Hunter JD; Logue GL; Joyner JT
    Arch Intern Med; 1982 Feb; 142(2):386-8. PubMed ID: 7059268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.